Steve Aselage, Director of Biocryst Pharmaceuticals BCRX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 24/06/12.

SA

SA

Steve Aselage

Director

Company

Biocryst Pharmaceuticals BCRX

First filing

23/03/16

Trades

7 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

24/06/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Biocryst PharmaceuticalsBCRX	Open-market buy	24/05/24	24/05/29	2,500 sh	$6.40	$16,000	No record